SCHEMBL28679088

SCHEMBL28679088

COC(C)C(=O)NC1(Cc2ccccn2)CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RET P07949 2/20 0.48
GPR119 Q8TDV5 2/20 0.42
TSHR P16473 3/20 0.41
ALOX15 P16050 1/20 0.41
OPRD1 P41143 1/20 0.41
OPRK1 P41145 1/20 0.41
JAK2 O60674 1/20 0.40
JAK1 P23458 1/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2D6 P10635 2/20 0.40
HSD17B10 Q99714 2/20 0.40
CYP2C19 P33261 1/20 0.40
ATM Q13315 1/20 0.39
POLB P06746 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
THRB P10828 1/20 0.39
EPHX2 P34913 1/20 0.39
CNR2 P34972 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29971642 1.00 RET (0.48) RETGPR119TSHRALOX15OPRD1
SCHEMBL20137436 0.87 RET (0.51) RETTSHROPRD1CYP3A4CYP2D6
SCHEMBL20137435 0.87 RET (0.51) RETTSHROPRD1CYP3A4CYP2D6
SCHEMBL20147950 0.86 RET (0.50) RETTSHRALOX15CYP2D6HSD17B10
SCHEMBL20069627 0.85 RET (0.52) RETTSHRALOX15CYP2D6HSD17B10
SCHEMBL25502428 0.84 RET (0.51) RETTSHRALOX15CYP3A4CYP2D6
SCHEMBL20137489 0.83 RET (0.47) RETGPR119OPRD1OPRK1JAK2
SCHEMBL20148111 0.80 RET (0.47) RETTSHRALOX15CYP2D6HSD17B10
SCHEMBL28664449 0.79 BACE1 (0.45) RETGPR119TSHRALOX15CNR2
SCHEMBL29970883 0.79 BACE1 (0.45) RETGPR119TSHRALOX15CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110177786-B Substituted pyrazolo [1,5-A ] pyridine compounds as RET kinase inhibitors 阿雷生物药品公司 2021-12-14 CN disclosed